News

March 6,2017
Posted by
Emanuela Fina PhD

Many types of cancer are capable of spreading or metastasizing to the brain including lung, breast, melanoma and colorectal cancer. There is no cure for metastatic cancer of any type, but treating brain metastasis poses unique challenges.

In two recent review articles, President-Elect of the Metastasis Research Society, Dr. Dihua Yu, and colleagues discuss what is currently known about the complex biology of brain metastasis and which therapies or strategies are most promising.

February 15,2017
Posted by
Katherine Bankaitis PhD

Past-President of the Metastasis Research Society (MRS), Dr. Patricia Steeg of the NCI, has been appointed to an Implementation Committee of the Beau Biden Cancer Moonshot in the U.S.  The goal of the Moonshot effort is to make a decade’s worth of progress in cancer research in just 5 years.  The initiative is a collaborative effort between researchers, clinicians, and patient advocates.

February 7,2017
Posted by
Katherine Bankaitis PhD

Young (age 15-45) women living with metastatic breast cancer (MBC) face unique challenges and deserve high quality support to feel prepared and confident in making informed treatment and life choices.  

January 12,2017
Posted by
Katherine Bankaitis PhD


CLICK HERE TO VIEW THE WEBINAR ON YOUTUBE

January 11,2017
Posted by
Venkatesh Krishnan PhD

Metastasis is the process by which cancer cells that originate in one organ, spread to a new site or organ within the body. It is the number one cause of all cancer-related deaths worldwide as confirmed by the World Health Organization.

January 3,2017
Posted by
Katherine Bankaitis, PhD

Metastasis is the spread of cancer from the original or primary site in the body to a new site, and it is still the cause of 90% of all cancer-related deaths (American Cancer Society).

Last year, the United States Congress passed the 2016 Defense Appropriations Bill directed at the Department of Defense (DoD) with the goal of accelerating clinical and translational metastatic cancer research. The Metastatic Cancer Research Task Force chaired by Craig Shriver, MD was then established under the direction of the Assistant Secretary of Defense (Health Affairs).

December 28,2016
Posted by
Katherine Bankaitis PhD

Non-small cell lung cancer (NSCLC) tumors can have mutations in the epidermal growth factor receptor (EGFR) protein that makes them sensitive to EGFR inhibitors.  Anti-EGFR therapy (typically gefitinib or erlotinib) is often an effective treatment option against these tumors until the cancer spreads (metastasizes) from the lung to the brain where it forms metastatic brain tumors. 

December 19,2016
Posted by
Lucia Borriello PhD

Infertility caused by chemotherapy is an unfortunate problem that many cancer patients face. Although chemotherapy can be effective for treating cancer in young women and girls, their ability to conceive following chemotherapy is markedly reduced.

November 18,2016
Posted by
Megan King of Tigerlily Foundation

Young (age 15-45) women living with metastatic breast cancer (MBC) face unique challenges and deserve high quality support to feel prepared and confident in making informed treatment and life choices. 

November 11,2016
Posted by
Emanuela Fina

Blood tests called liquid biopsies can be used to collect circulating tumor cells (CTCs) from the bloodstream of cancer patients with solid tumors like breast cancer.  These non-invasive tests are becoming an important tool for monitoring response to therapy and for providing prognostic information.  But, could CTCs themselves be targeted to stop the most lethal aspect of cancer, cancer metastasis?